Navigation Links
Woodlyn Lensmeter

ProductsWoodlyn Lensmeter
Company Woodlyn International
Item Woodlyn Lensmeter
Features Power wheel on either side permitting convenient single hand operation of the axis and sphere power. Lever operated lens table, a lens holder that self adjusts to any lens surface. Ability to measures contact lens power in the vertical 90 degree position.
Description Woodlyn Lensmeter is designed to be used in either a prescription laboratory setting or professional office. Its titable position angle offers personal comfort. The easily operated marking device provides nylon pins to prevent scratching.
Info Woodlyn International
Customer Service: (800) 331-7389
Web site: http://woodlynintl.com/

Related medicine products :

1. Woodlyn Refractor
2. CL-100 4.0 Computerized Lensmeter
3. Auto Lensmeter LM-970
4. Projection Digital Lensmeter LM-770
5. Huvitz CLM-3100P Auto Lensmeter
6. Mirae CLM-3000 Auto Lensmeter
7. LM-S1 Lensmeter
8. LM-8/8E Lensmeter
9. LM-101 Standard Lensmeter
10. LM-201 Standard Lensmeter
11. Burton 2021 Lensmeter
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...tional high-end microplate reader with outstanding... modes., Fluorescence Intensity - FRET , Fluores... HTRF, AlphaScreen , Luminescence , , , PHERAst...der with fastest read times. The ultimate solution...
Medicine Products:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...es that not only fight cocaine and methamphetamine...ms. The study was conducted by a team of researc...at Baylor College of Medicine (BCM). As part of t...xamined the effect of the vaccines on subjects adm...
...le of detecting and measuring all known forms of h...r physicians in managing patient therapy. Abbott ...nced today that Abbott has received CE marking for...eaction) test for monitoring hepatitis B (HBV) vir...
...ial Programme for Research and Training in Tropica...trengthening and expanding research to prevent and...rategy builds on the programmes 30-year record of ...egies and enhancing research capacity in countries...
...Advisory Board for its transplantation programs. I...on of its United States (U.S.) clinical developme... and Larry Chodoff LifeCycle Pharma A/S OMX:LCP) t...Scientific Advisory Board (SAB) of experts in the ...
Other Medicine News:Health News:Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe 2Health News:Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe 3Health News:LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation 2
(Date:9/4/2008)...Data Published in ,The Lancet, and Presented at ES...- Results from a new international,study, the GISS...d dose of,omega-3 acid ethyl esters reduced all ca...scular reasons in patients with chronic heart,fail...nline version of ,The,Lancet, and were presented a...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to be Pre...tCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) announced...,an investigational anti-CTLA-4 antibody, in mela...ons at the 33rd Congress of the European Society,f...-16, 2008 in Stockholm.,Many of the following abst...
(Date:9/3/2008)...ays: Wrong Question Asked. Wrong Children Studied....PRNewswire-USNewswire/ -- A Centers for Disease,Co...aims there is no link,between the MMR vaccine and ... this study does nothing to dispel the growing pub...aises several questions concerning design,and meth...
(Date:9/3/2008)...SELS, Belgium and GENEVA, Sept. 3 /- ...lestone in CHO based monoclonal antibody,productio...over 31 grams,per liter. This record level was acc...logies: (1) a high-performance stable Selexis CHO,... leading scientists at,Selexis SA using their prop...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3CDC Misses Target With Flawed MMR/Autism Study 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3How fast youll age is written in the bones TAU research finds 16411 1How fast youll age is written in the bones TAU research finds 16411 2Boston College biologists build a better mouse model for cancer research 16409 1Boston College biologists build a better mouse model for cancer research 16409 2UNICEF Launches Initiative to Provide Assistance to Children With Disabilities in Vietnam 16407 1UNICEF Launches Initiative to Provide Assistance to Children With Disabilities in Vietnam 16407 2UNICEF Launches Initiative to Provide Assistance to Children With Disabilities in Vietnam 16407 3UNICEF Launches Initiative to Provide Assistance to Children With Disabilities in Vietnam 16407 4An Eye Opening Look at Insomnia 16405 1An Eye Opening Look at Insomnia 16405 2
... 2007,/PRNewswire-FirstCall/ -- Cell Genesys, Inc....nical trial of GVAX immunotherapy,for pancreatic c...ney Kimmel Cancer Center. The trial enrolled 60 pa...d GVAX after surgical,resection of their tumor and...n overall survival for these patients was previous...
...000, 2002 , CHICAGO/DARMSTADT, Germany, June 4, 20...d today at the American Society of,Clinical Oncolo...e,clinical activity of cilengitide in patients wit...rly aggressive form of brain tumor.,Cilengitide is...he,tumor and its vasculature. , Fifty-two patients...
Other Medicine Technology:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 2Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 3Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 4Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 5Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 2Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 3Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 4Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 5